SpayVac-for-Wildlife and BioVaxys jointly have partnered with the Elephant and Wildlife Clinic, Faculty of Veterinary Medicine of Chiang Mai University in Thailand, to test SpayVac, a contraceptive vaccine, in captive…
SHINE Technologies was awarded $32 million from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the organization announced today. According to a release, the funds will aid in the…
Forward BIOLABS is one of seven organizations receiving Entrepreneurship Partner Grants from the Wisconsin Economic Development Corporation (WEDC), the organizations announced today. According to a release, Forward BIOLABS is receiving…
The Wisconsin Biohealth Tech Hub secured $49 million in funding from Phase 2 of the U.S. Department of Commerce’s Economic Development and Administration (EDA) Regional Technology and Innovations Hub…
SHINE Technologies has partnered with Zeno Power, a developer of commercial Radioisotope Power Systems (RPSs), the company recently announced. According to a release, SHINE plans to provide Zeno with Strontium-90…
Voximetry has partnered with Flywheel, a medical imaging AI platform powering healthcare innovation through streamlined data management, curation and analysis, the company announced recently. According to a release, the collaboration…
NorthStar Medical Radioisotopes has amended and expanded its existing collaboration with Monopar Therapeutics, the company announced recently. According to a release, the long-term, non-exclusive master supply agreement states that NorthStar…
SHINE Technologies announced recently that it has partnered with Blue Earth Therapeutics, a company focused on developing innovative radiopharmaceuticals. According to a release, SHINE has provided to Blue Earth Therapeutics…
Cellectar Biosciences is entering a strategic partnership with City of Hope Cancer Center, one of the largest cancer research and treatment organizations in the United States, the organization announced recently….
NorthStar Medical Radioisotopes is signing a clinical supply agreement with Clarity Pharmaceuticals for the production of 67Cu-SAR-bisPSMA drug product for Clarity’s Phase I/II and Phase III trials, the company recently…
